Alexion Pharmaceuticals
$96.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$96.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.88 (-2.91%) Today
+$0.59 (+0.62%) As of 5:08 PM EST after-hours
Why Robinhood?
You can buy or sell ALXN and other stocks, options, ETFs, and crypto commission-free!
About ALXN
Alexion Pharmaceuticals, Inc. Common Stock, also called Alexion Pharmaceuticals, is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Read More Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.
Employees
3,082
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
22.70B
Price-Earnings Ratio
9.64
Dividend Yield
—
Average Volume
2.47M
High Today
$100.85
Low Today
$94.78
Open Price
$100.51
Volume
3.98M
52 Week High
$141.86
52 Week Low
$94.59
Collections
Analyst Ratings
78%
of 23 ratings
Buy
78%
Hold
22%
Sell
0%
ALXN Earnings
$0.00
$0.93
$1.86
$2.79
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 23, Pre-Market
People Also Bought
Bristol-Myers Squibb
7,782
$61.66
-3.61%Micron Technology
44,447
$52.73
-4.14%Alibaba
139,870
$206.00
-0.08%Applied Materials
16,897
$59.25
-3.00%Gilead Sciences
18,063
$70.45
-3.36%Bristol-Myers Squibb Comp...
$3.52
-3.55%AbbVie
27,048
$88.89
-4.56%Incyte
1,223
$77.52
-1.71%Baidu
17,088
$124.43
-1.11%142,641
$197.36
-1.67%Vertex Pharmaceuticals
2,367
$230.00
-2.96%Delta Air Lines
19,273